Endothelin-1 is produced by endometrial stromal and glandular epithelial cells, with expression peaking during the premenstrual-menstrual phase and upregulated by TGF-beta and IL-1 alpha, suggesting a role in modulating endometrial blood flow.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open ET-1 as a modulator of endometrial function pending human validation.
We present evidence that endothelin-1 (ET-1) is produced by two distinct cell types (other than vascular endothelial cells) in human endometrial tissue. The supportive findings of this investigation are summarized as follows: 1) prepro-ET-1 mRNA is present in endometrial tissue and in separated endometrial stromal and glandular epithelial cells in culture; 2) immunoreactive ET is secreted into the medium of isolated endometrial stromal cells and glandular epithelium maintained in culture; and 3) the level of prepro-ET-1 mRNA in endometrial tissues obtained at the premenstrual-menstrual phase of the endometrial cycle is greater than that in tissues from the proliferative or early and midsecretory phases. We also found that transforming growth factor-beta and interleukin-1 alpha act to increase the levels of prepro-ET-1 mRNA in endometrial stroma cells in monolayer culture. We speculate that ET-1 derived from endometrial stromal cells may act on the adventitial surface of contiguous spiral arterioles of the endometrium to modulate endometrial blood flow.
No takes yet. Share an insight, caveat, or question.
Economos et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: